Meeder Advisory Services’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Sell |
1,546
-505
| -25% | -$111K | 0.02% | 461 |
|
|
2025
Q1 | $459K | Buy |
2,051
+400
| +24% | +$89.6K | 0.03% | 372 |
|
|
2024
Q4 | $541K | Buy |
1,651
+280
| +20% | +$91.7K | 0.03% | 334 |
|
|
2024
Q3 | $412K | Sell |
1,371
-53
| -4% | -$15.9K | 0.03% | 382 |
|
|
2024
Q2 | $469K | Buy |
1,424
+270
| +23% | +$88.9K | 0.03% | 326 |
|
|
2024
Q1 | $457K | Buy |
1,154
+7
| +0.6% | +$2.77K | 0.05% | 291 |
|
|
2023
Q4 | $404K | Sell |
1,147
-24
| -2% | -$8.45K | 0.05% | 295 |
|
|
2023
Q3 | $439K | Sell |
1,171
-274
| -19% | -$103K | 0.06% | 283 |
|
|
2023
Q2 | $553K | Buy |
1,445
+108
| +8% | +$41.3K | 0.06% | 267 |
|
|
2023
Q1 | $463K | Buy |
+1,337
| New | +$463K | 0.05% | 290 |
|